Safety and efficacy of concurrent use with Tetanus-Serum from Intervet has been demonstrated.
Network License Enable concurrent usage and compliance across the organization.
Additionally, only a few studies reported use of concurrent positive controls.
There will, therefore, be no need for concurrent proceedings.
